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We report the untypical clinical course of a previously healthy two-year-old girl, who died suddenly and unexpectedly after an
episode of vomiting. At forensic autopsy no other pathological ﬁndings could be diagnosed than multiple reddish, sunken areas
in brain stem, mesencephalon, and pons. Histologically they presented as areas of spongiosis of the neuropil with prominent
endothelial hyperplasia and vascular proliferation whereas nerve cells were well preserved. On the basis of the characteristic
neuropathological ﬁndings in combination with the age of the child, we had to take into consideration that the child might have
died from subacute necrotizing encephalomyelopathy (Leigh’s Disease) despite the untypical, fulminant clinical course.
1.Introduction
Normally subacute necrotizing encephalomyelopathy
presents with a clinical course of at least several months
and impressive clinical signs. But possibly there are
undocumented, unexpected deaths which could have been
diagnosed as subacute necrotizing encephalopathy only in
postmortem examiniation, if performed, due to atypical
progression.
2.CaseReport
A previously healthy 24-month-old girl with strabismus
concomitans, associated with a nystagmus, presented to a
pediatric hospital. Furthermore the girl’s mother reported
unspeciﬁc symptoms like attention deﬁcits, decrease in
alertness, increased nervousness and “interaction problems”.
On examination the girl was found to be in general
good health with appropriate nutrition. Physical and psy-
chomotor development was documented to be normal.
Clinical examinations, including laboratory examinations as
well as a neurological examination with magnetic resonance
imaging (MRI), which was performed as a precaution to
exclude an intracranial disease, were all found to be normal.
Electroencephalography showed a small decrease in alert-
ness associated with sharp-wave and theta rhythm activity.
Ophthalmologically a strabismus concomitans divergence
was diagnosed. The child was allowed to return home but
ophthalmologic follow-up was recommended.
Three months later the child started vomiting at home.
Finally the paramedics were called as the girl lost hemor-
rhagic mucus from her nose. Shortly afterwards she lost
consciousness and when the paramedics arrived she was
already clinically dead. Reanimation was unsuccessful. Death
was attributed to aspiration during an assumed epileptic
seizure.
Forensic postmortem examination of the girl showed few
irregularities; in particular the heart and lungs were free
of any pathological ﬁndings. Laboratory examinations of
glucose metabolism as well as chemical-toxicological studies
showed normal results except for increased lactate concen-
tration in blood (47.9mmol/l; refernce: <2.4mmol/l) and
cerebrospinal ﬂuid (26.3mmol/l; reference: 1.1–2.1mmol/l).
The brain weighted 1061g. Leptomeninges and gyration
patterns were unremarkable; marked signs of edema and
signiﬁcant tonsillar herniation were seen. However, on
horizontal sections small reddish foci of tissue softening with
cysticappearancewereseenwithinthepons,mesencephalon,
and medulla oblongata (Figures 1 and 2).2 Case Reports in Medicine
Figure 1: Reddish, sunken foci within the pons.
Figure 2: Cystic, reddish areas in mesencephalon, pons, and
medulla oblongata.
After ﬁxation the brain was histologically examined
(hematoxylin and eosin, cresyl-violet, Luxol-Fast-Blue, van-
Gieson Elastica, PAS, and Prussian Blue).
Deparaﬃnized5-µm-thicksectionswereimmunostained
with the ABC method. For labelling astrocytes a mono-
clonal antibody against glial ﬁbrillary acidic protein (GFAP,
dilution 1:100, DAKO, Germany) was used; for microglia a
monoclonal antibody against the HLA-DP, DQ, DR antigen
(CR 3/43, dilution 1:100, DAKO, Germany, predigestion
with formic acid) was used. Antigens were detected with a
Histostain-Plus Peroxidase Kit (Zytomed, Germany).
On histological examination there was widespread
hypoxic-ischemic nerve cell damage within the major lobes,
dentate nucleus, and Purkinje cell layer. On sections of the
caudate nuclei, thalamus, hypothalamus, mesencephalon,
pons, and medulla oblongata there were widespread foci of
spongiosisoftheneuropilwithprominentendothelialhyper-
plasia and vascular proliferation. Besides hypoxic-ischemic
changes, the nerve cells were relatively well preserved
(Figure 3). Immunostaining for GFAP revealed marked
astrogliosis. The white matter of the cerebral hemispheres,
the hippocampal formation, the medulla oblongata, and the
mamillary bodies were unremarkable.
3. Discussion
Theraresubacutenecrotizingencephalomyelopathywasﬁrst
described by Leigh [1] as a clinically and etiologically highly
variable, progressive syndrome seen particularly in pediatric
Figure 3: Histological picture of the macroscopic lesion of the pons
(HE, 100-fold).
populationalthoughafewjuvenileandadultcasesareknown
[2, 3].
The unspeciﬁc, heterogenic, and apparently age-
dependent variation in clinical symptoms and course may
possibly be attributed to identiﬁcation of diﬀerent enzyme
defects in this disease. Already mitochondrial as well as
nuclear DNA enzyme defects have been found [2, 4, 5] that
determine similar clinical courses but occur at diﬀerent ages.
Clinical symptoms are also determined by which area of the
brain is aﬀected.
The infantile form usually begins during the ﬁrst two
years of life with unspeciﬁc symptoms and a slowing in
psychomotor development. Other symptoms include atten-
tion deﬁcit, limb hypotonia, visual irregularities including
nystagmus, poor strength, emesis, unwillingness to eat,
and loss of weight [2, 4, 6]. Neurological symptoms such
as ataxia, deﬁcits of the pyramidal tract, apraxia, and
myoclonus often develop, followed by ophthalmoplegia and
respiratory diﬃculties as a sign of brain stem damage [2].
Congenital cytochrome-c-oxidase deﬁciency, pyruvate-
dehydrogenasedeﬁciencyaswellasbiotinidasedeﬁciencyare
knowntocausetheseclinicalsymptoms[4,7,8].Thesestates
probably have an autosomal-recessive inheritance although
mitochondrial and maternal inheritance are being discussed
and sporadic cases are known [3, 4]. Genetic irregularities
could only be found in approximately 50% of all patients,
showing that there are many other biochemical irregularities
which could lead to the clinical syndrome of Leigh’s disease
[8].
Speciﬁc biochemical tests are still lacking, however
lactate acidosis and increased lactate-pyruvate quotient in
plasma and CSF are nearly always found [4]. The search
for mitochondrial DNA mutations as a common cause for
Leigh’s Disease and biochemical investigation of muscle
biopsies still remain the gold standard in diagnosis [9, 10].
On neuropathological examination of the brain symmet-
rical, central lesions of red brown colour in areas of the brain
stem, putamen, basal ganglia, thalamus, and posterior horn
of the spinal cord can macroscopically be identiﬁed [6].
In early stage neuropil is damaged by spongiosis, fol-
lowed by capillary proliferation, astrogliosis, and increased
numbers of macrophages. In the course of the diseaseCase Reports in Medicine 3
demyelination occurs, which leaves neurons and axons
nearly intact. That allows, for example, diﬀerentiation from
ischemic/hypoxic lesions [1, 2, 6, 7]. In particular the
mesencephalon, pons, caudate, medulla oblongata, central
cranialnervenuclei,inferiorolivarynuclei,cerebellum,basal
ganglia, and the optic nerve are aﬀected [6].
Destruction of cerebral tissue causes progressive neuro-
logical dysfunction, which regularly ends in death at about
two years after diagnosis due to central respiratory paralysis.
Currently there exists no curative therapy [3, 4, 6].
MRI shows symmetrical, hypodense (T1) and hyper-
dense (T2) lesions in the basal ganglia, involving especially
the area of the caudate and putamen. Similar lesions
are also seen in Wernicke’s encephalopathy, multiple scle-
rosis, Wilson’s disease, amino acid urea, mitochondrial
encephalomyelopathies, and various forms of intoxication
[3]. In contrast to Wernicke’s encephalopathy mamillary
bodies are spared from pathological changes [3]. A diﬀer-
entiation to Wilson’s disease is possible through laboratory
studies of the blood [4].
At the moment most symptomatic therapies try to
improve the oxidative and bioenergetic capabilities of the
mitochondria [6]. The use of coenzyme Q10, thiamine, and
carnitine may cause a decrease in severity of symptoms in
af e wc a s e s[ 6]. Cacic et al. report that a 19-year-old man
symptoms were kept stable for at least four years by a therapy
including levodopa, carbidopa, and creatinine monohydrate
[8].
4. Conclusions
In the presented case the diagnosis of Leigh’s Disease
could only be reached postmortem although three months
prior to death MRI scans and laboratory examinations had
been performed. They showed normal ﬁndings, furthermore
other typical symptoms—like delay in psychomotor devel-
opment, weakness, eating diﬃculty, or typical neurological
symptoms—were not observed. The clinical symptoms on
the day of death were probably primarily of acute cerebral
origin. However, postmortem examination showed morpho-
logical ﬁndings of the child’s brain which are speciﬁc to
Leigh’s disease. An increased lactate concentration in blood
and CSF could be conﬁrmed in postmortem examination,
which is typical to Leigh’s disease, but can be seen in
many autopsies because of the generalized agonal cellular
hypoxemia.
It is to be assumed that this case report describes an
unusual,“acute”courseofthenormallysubacutenecrotizing
encephalomyelopathy with a strikingly short and mostly
unnoticeable clinical course.
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